Stock Events

Stock Events

Alnylam Pharmaceuticals (ALNY) Q4 2024 Earnings

31OctConfirmed

Q1 2024

Q2 2024

Q3 2024

Q4 2024

-1.26

-0.88

-0.51

-0.13

Details

Expected EPS

-0.916627

Actual EPS

-0.87

Surprise EPS

0.05

Surprise Percent

+5.09%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -0.87 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.